Fatemeh Sadat Majedi
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Fatemeh Sadat Majedi has a total of 81 co-authors. Here are the top co-authors by number of shared publications:
- Mohammad Mahdi Hasani-Sadrabadi
Department of Bioengineering, University of California, Los Angeles, CA 90095, USA
29 shared publications Erfan Dashtimoghadam
Department of Developmental Sciences, Marquette University School of Dentistry, Milwaukee, WI, USA
25 shared publications- Arnaud Bertsch
Microsystems Laboratory, Ecole Polytechnique Federale de Lausanne (EPFL), 1015 Lausanne, Switzerland
12 shared publications Homayoun Moaddel
Hydrogen & Fuel Cell, Inc., Arcadia, California 91006, United States
9 shared publications- Philippe Renaud
Microsystems Laboratory 4, Institute of Electrical and Micro Engineering, Ecole Polytechnique Fédérale de Lausanne (EPFL) , Lausanne
8 shared publications - Karl I. Jacob
School of Materials Science and Engineering, Georgia Institute of Technology, Atlanta, USA
6 shared publications
Latest Publications
- 22 December 2022
- Published by Springer Nature in Nature Biomedical Engineering
- Vol. 7 (1) , 56-71
Systemic enhancement of antitumour immunity by peritumourally implanted immunomodulatory macroporous scaffolds
A tumour microenvironment abundant in regulatory T (Treg) cells aids solid tumours to evade clearance by effector T cells. Systemic strategies to suppress Treg cells or to augment immunity can elicit autoimmune side effects, cytokine storms and other toxicities. Here we report the design, fabrication and therapeutic performance of a biodegradable macroporous scaffold, implanted peritumourally, that releases a small-molecule inhibitor of transforming growth factor β to suppress Treg cells, chemokines to attract effector T cells and antibodies to stimulate them. In two mouse models of aggressive tumours, the implant boosted the recruitment and activation of effector T cells into the tumour and depleted it of Treg cells, which resulted in an ‘immunological abscopal effect’ on distant metastases and in the establishment of long-term memory that impeded tumour recurrence. We also show that the scaffold can be used to deliver tumour-antigen-specific T cells into the tumour. Peritumourally implanted immunomodulatory scaffolds may represent a general strategy to enhance T-cell immunity and avoid the toxicities of systemic therapies.
- 22 December 2022
- Published by Springer Nature in Nature Biomedical Engineering
- Vol. 7 (1) , 56-71
Systemic enhancement of antitumour immunity by peritumourally implanted immunomodulatory macroporous scaffolds
A tumour microenvironment abundant in regulatory T (Treg) cells aids solid tumours to evade clearance by effector T cells. Systemic strategies to suppress Treg cells or to augment immunity can elicit autoimmune side effects, cytokine storms and other toxicities. Here we report the design, fabrication and therapeutic performance of a biodegradable macroporous scaffold, implanted peritumourally, that releases a small-molecule inhibitor of transforming growth factor β to suppress Treg cells, chemokines to attract effector T cells and antibodies to stimulate them. In two mouse models of aggressive tumours, the implant boosted the recruitment and activation of effector T cells into the tumour and depleted it of Treg cells, which resulted in an ‘immunological abscopal effect’ on distant metastases and in the establishment of long-term memory that impeded tumour recurrence. We also show that the scaffold can be used to deliver tumour-antigen-specific T cells into the tumour. Peritumourally implanted immunomodulatory scaffolds may represent a general strategy to enhance T-cell immunity and avoid the toxicities of systemic therapies.
- Open Access
- 2 June 2020
- Published by Rockefeller University Press in Journal of Experimental Medicine
- Vol. 217 (8)
Mechanosensing through YAP controls T cell activation and metabolism
Upon immunogenic challenge, lymph nodes become mechanically stiff as immune cells activate and proliferate within their encapsulated environments, and with resolution, they reestablish a soft baseline state. Here we show that sensing these mechanical changes in the microenvironment requires the mechanosensor YAP. YAP is induced upon activation and suppresses metabolic reprogramming of effector T cells. Unlike in other cell types in which YAP promotes proliferation, YAP in T cells suppresses proliferation in a stiffness-dependent manner by directly restricting the translocation of NFAT1 into the nucleus. YAP slows T cell responses in systemic viral infections and retards effector T cells in autoimmune diabetes. Our work reveals a paradigm whereby tissue mechanics fine-tune adaptive immune responses in health and disease.
- 2 June 2020
- Published by Rockefeller University Press in Journal of Experimental Medicine
- Vol. 217 (8)
Open AccessMechanosensing through YAP controls T cell activation and metabolism
Upon immunogenic challenge, lymph nodes become mechanically stiff as immune cells activate and proliferate within their encapsulated environments, and with resolution, they reestablish a soft baseline state. Here we show that sensing these mechanical changes in the microenvironment requires the mechanosensor YAP. YAP is induced upon activation and suppresses metabolic reprogramming of effector T cells. Unlike in other cell types in which YAP promotes proliferation, YAP in T cells suppresses proliferation in a stiffness-dependent manner by directly restricting the translocation of NFAT1 into the nucleus. YAP slows T cell responses in systemic viral infections and retards effector T cells in autoimmune diabetes. Our work reveals a paradigm whereby tissue mechanics fine-tune adaptive immune responses in health and disease.
- 24 April 2020
- Published by Elsevier in Biomaterials
- Vol. 252, 120058
T-cell activation is modulated by the 3D mechanical microenvironment
- 24 April 2020
- Published by Elsevier in Biomaterials
- Vol. 252, 120058
T-cell activation is modulated by the 3D mechanical microenvironment
- 3 September 2019
- Published by American Chemical Society (ACS) in Nano Letters
- Vol. 19 (10) , 6945-6954
Augmentation of T-Cell Activation by Oscillatory Forces and Engineered Antigen-Presenting Cells
Activation of T cells by antigen presenting cells (APCs) initiates their proliferation, cytokine production, and killing of infected or cancerous cells. We and others have shown that T-cell receptors require mechanical forces for triggering, and these forces arise during the interaction of T cells with APCs. Efficient activation of T cells in vitro is necessary for clinical applications. In this paper, we studied the impact of combining mechanical, oscillatory movements provided by an orbital shaker with soft, biocompatible, artificial APCs (aAPCs) of various sizes and amounts of antigen. We showed that these aAPCs allow for testing the strength of signal delivered to T cells, and enabled us to confirm that that absolute amounts of antigen engaged by the T cell are more important for activation than the density of antigen. We also found that when our aAPCs interact with T cells in the context of an oscillatory mechanoenvironment, they roughly double antigenic signal strength, compared to conventional, static culture. Combining these effects, our aAPCs significantly outperformed the commonly used Dynabeads. We finally demonstrated that tuning the signal strength down to a submaximal “sweet spot” allows for robust expansion of induced regulatory T cells. In conclusion, augmenting engineered aAPCs with mechanical forces offers a novel approach for tuning of T-cell activation and differentiation.
- 3 September 2019
- Published by American Chemical Society (ACS) in Nano Letters
- Vol. 19 (10) , 6945-6954
Augmentation of T-Cell Activation by Oscillatory Forces and Engineered Antigen-Presenting Cells
Activation of T cells by antigen presenting cells (APCs) initiates their proliferation, cytokine production, and killing of infected or cancerous cells. We and others have shown that T-cell receptors require mechanical forces for triggering, and these forces arise during the interaction of T cells with APCs. Efficient activation of T cells in vitro is necessary for clinical applications. In this paper, we studied the impact of combining mechanical, oscillatory movements provided by an orbital shaker with soft, biocompatible, artificial APCs (aAPCs) of various sizes and amounts of antigen. We showed that these aAPCs allow for testing the strength of signal delivered to T cells, and enabled us to confirm that that absolute amounts of antigen engaged by the T cell are more important for activation than the density of antigen. We also found that when our aAPCs interact with T cells in the context of an oscillatory mechanoenvironment, they roughly double antigenic signal strength, compared to conventional, static culture. Combining these effects, our aAPCs significantly outperformed the commonly used Dynabeads. We finally demonstrated that tuning the signal strength down to a submaximal “sweet spot” allows for robust expansion of induced regulatory T cells. In conclusion, augmenting engineered aAPCs with mechanical forces offers a novel approach for tuning of T-cell activation and differentiation.
- 23 April 2018
- Published by Wiley in Advanced Materials
- Vol. 30 (23) , e1706780
Mechanobiological Mimicry of Helper T Lymphocytes to Evaluate Cell–Biomaterials Crosstalk
The unique properties of immune cells have inspired many efforts in engineering advanced biomaterials capable of mimicking their behaviors. However, an inclusive model capable of mimicking immune cells in different situations remains lacking. Such models can provide invaluable data for understanding immune–biomaterial crosstalk. Inspired by CD4+ T cells, polymeric microparticles with physicochemical properties similar to naïve and active T cells are engineered. A lipid coating is applied to enhance their resemblance and provide a platform for conjugation of desired antibodies. A novel dual gelation approach is used to tune the elastic modulus and flexibility of particles, which also leads to elongated circulation times. Furthermore, the model is enriched with magnetic particles so that magnetotaxis resembles the chemotaxis of cells. Also, interleukin‐2, a proliferation booster, and interferon‐γ cytokines are loaded into the particles to manipulate the fates of killer T cells and mesenchymal stem cells, respectively. The penetration of these particles into 3D environments is studied to provide in vitro models of immune‐biomaterials crosstalk. This biomimicry model enables optimization of design parameters required for engineering more efficient drug carriers and serves as a potent replica for understanding the mechanical behavior of immune cells.
- 23 April 2018
- Published by Wiley in Advanced Materials
- Vol. 30 (23) , e1706780
Mechanobiological Mimicry of Helper T Lymphocytes to Evaluate Cell–Biomaterials Crosstalk
The unique properties of immune cells have inspired many efforts in engineering advanced biomaterials capable of mimicking their behaviors. However, an inclusive model capable of mimicking immune cells in different situations remains lacking. Such models can provide invaluable data for understanding immune–biomaterial crosstalk. Inspired by CD4+ T cells, polymeric microparticles with physicochemical properties similar to naïve and active T cells are engineered. A lipid coating is applied to enhance their resemblance and provide a platform for conjugation of desired antibodies. A novel dual gelation approach is used to tune the elastic modulus and flexibility of particles, which also leads to elongated circulation times. Furthermore, the model is enriched with magnetic particles so that magnetotaxis resembles the chemotaxis of cells. Also, interleukin‐2, a proliferation booster, and interferon‐γ cytokines are loaded into the particles to manipulate the fates of killer T cells and mesenchymal stem cells, respectively. The penetration of these particles into 3D environments is studied to provide in vitro models of immune‐biomaterials crosstalk. This biomimicry model enables optimization of design parameters required for engineering more efficient drug carriers and serves as a potent replica for understanding the mechanical behavior of immune cells.
- 8 January 2018
- Published by Wiley in Advanced Materials
- Vol. 30 (7)
Cytokine Secreting Microparticles Engineer the Fate and the Effector Functions of T‐Cells
T‐cell immunotherapy is a promising approach for cancer, infection, and autoimmune diseases. However, significant challenges hamper its therapeutic potential, including insufficient activation, delivery, and clonal expansion of T‐cells into the tumor environment. To facilitate T‐cell activation and differentiation in vitro, core–shell microparticles are developed for sustained delivery of cytokines. These particles are enriched by heparin to enable a steady release of interleukin‐2 (IL‐2), the major T‐cell growth factor, over 10+ d. The controlled delivery of cytokines is used to steer lineage specification of cultured T‐cells. This approach enables differentiation of T‐cells into central memory and effector memory subsets. It is shown that the sustained release of stromal cell‐derived factor 1α could accelerate T‐cell migration. It is demonstrated that CD4+ T‐cells could be induced to high concentrations of regulatory T‐cells through controlled release of IL‐2 and transforming growth factor beta. It is found that CD8+ T‐cells that received IL‐2 from microparticles are more likely to gain effector functions as compared with traditional administration of IL‐2. Culture of T‐cells within 3D scaffolds that contain IL‐2‐secreting microparticles enhances proliferation as compared with traditional, 2D approaches. This yield a new method to control the fate of T‐cells and ultimately to new strategies for immune therapy.
- 8 January 2018
- Published by Wiley in Advanced Materials
- Vol. 30 (7)
Cytokine Secreting Microparticles Engineer the Fate and the Effector Functions of T‐Cells
T‐cell immunotherapy is a promising approach for cancer, infection, and autoimmune diseases. However, significant challenges hamper its therapeutic potential, including insufficient activation, delivery, and clonal expansion of T‐cells into the tumor environment. To facilitate T‐cell activation and differentiation in vitro, core–shell microparticles are developed for sustained delivery of cytokines. These particles are enriched by heparin to enable a steady release of interleukin‐2 (IL‐2), the major T‐cell growth factor, over 10+ d. The controlled delivery of cytokines is used to steer lineage specification of cultured T‐cells. This approach enables differentiation of T‐cells into central memory and effector memory subsets. It is shown that the sustained release of stromal cell‐derived factor 1α could accelerate T‐cell migration. It is demonstrated that CD4+ T‐cells could be induced to high concentrations of regulatory T‐cells through controlled release of IL‐2 and transforming growth factor beta. It is found that CD8+ T‐cells that received IL‐2 from microparticles are more likely to gain effector functions as compared with traditional administration of IL‐2. Culture of T‐cells within 3D scaffolds that contain IL‐2‐secreting microparticles enhances proliferation as compared with traditional, 2D approaches. This yield a new method to control the fate of T‐cells and ultimately to new strategies for immune therapy.
- 1 September 2016
- Published by Elsevier in Colloids and Surfaces B: Biointerfaces
- Vol. 145, 802-811
Understanding biophysical behaviours of microfluidic-synthesized nanoparticles at nano-biointerface
- 1 September 2016
- Published by Elsevier in Colloids and Surfaces B: Biointerfaces
- Vol. 145, 802-811
Understanding biophysical behaviours of microfluidic-synthesized nanoparticles at nano-biointerface
- 12 August 2016
- Published by Springer Nature
- Vol. 171, 63-97
Electromagnetic Fields and Stem Cell Fate: When Physics Meets Biology
Controlling stem cell (SC) fate is an extremely important topic in the realm of SC research. A variety of different external cues mainly mechanical, chemical, or electrical stimulations individually or in combination have been incorporated to control SC fate. Here, we will deconstruct the probable relationship between the functioning of electromagnetic (EMF) and SC fate of a variety of different SCs. The electromagnetic (EM) nature of the cells is discussed with the emphasis on the effects of EMF on the determinant factors that directly and/or indirectly influence cell fate. Based on the EM effects on a variety of cellular processes, it is believed that EMFs can be engineered to provide a controlled signal with the highest impact on the SC fate decision. Considering the novelty and broad applications of applying EMFs to change SC fate, it is necessary to shed light on many unclear mechanisms underlying this phenomenon.
- 12 August 2016
- Published by Springer Nature
- Vol. 171, 63-97
Electromagnetic Fields and Stem Cell Fate: When Physics Meets Biology
Controlling stem cell (SC) fate is an extremely important topic in the realm of SC research. A variety of different external cues mainly mechanical, chemical, or electrical stimulations individually or in combination have been incorporated to control SC fate. Here, we will deconstruct the probable relationship between the functioning of electromagnetic (EMF) and SC fate of a variety of different SCs. The electromagnetic (EM) nature of the cells is discussed with the emphasis on the effects of EMF on the determinant factors that directly and/or indirectly influence cell fate. Based on the EM effects on a variety of cellular processes, it is believed that EMFs can be engineered to provide a controlled signal with the highest impact on the SC fate decision. Considering the novelty and broad applications of applying EMFs to change SC fate, it is necessary to shed light on many unclear mechanisms underlying this phenomenon.
- 1 May 2016
- Published by Elsevier in Nano Energy
- Vol. 23, 114-121
Ionic nanopeapods: Next-generation proton conducting membranes based on phosphotungstic acid filled carbon nanotube
- 1 May 2016
- Published by Elsevier in Nano Energy
- Vol. 23, 114-121
Ionic nanopeapods: Next-generation proton conducting membranes based on phosphotungstic acid filled carbon nanotube
- 22 March 2016
- Published by Wiley in Advanced Materials
- Vol. 28 (21) , 4134-4141
Microfluidic Manipulation of Core/Shell Nanoparticles for Oral Delivery of Chemotherapeutics: A New Treatment Approach for Colorectal Cancer
A microfluidics approach to synthesize core–shell nanocarriers with high pH tunability is described. The sacrificial shell protects the core layer with the drugs and prevents their release in the severe pH conditions of the gastrointestinal tract, while allowing for drug release in the proximity of a tumor. The proposed nanoparticulate drug-delivery system is designed for the oral administration of cancer therapeutics.
- 22 March 2016
- Published by Wiley in Advanced Materials
- Vol. 28 (21) , 4134-4141
Microfluidic Manipulation of Core/Shell Nanoparticles for Oral Delivery of Chemotherapeutics: A New Treatment Approach for Colorectal Cancer
A microfluidics approach to synthesize core–shell nanocarriers with high pH tunability is described. The sacrificial shell protects the core layer with the drugs and prevents their release in the severe pH conditions of the gastrointestinal tract, while allowing for drug release in the proximity of a tumor. The proposed nanoparticulate drug-delivery system is designed for the oral administration of cancer therapeutics.